Literature DB >> 16286925

The antioxidant function of the p53 tumor suppressor.

Anna A Sablina1, Andrei V Budanov, Galina V Ilyinskaya, Larissa S Agapova, Julia E Kravchenko, Peter M Chumakov.   

Abstract

It is widely accepted that the p53 tumor suppressor restricts abnormal cells by induction of growth arrest or by triggering apoptosis. Here we show that, in addition, p53 protects the genome from oxidation by reactive oxygen species (ROS), a major cause of DNA damage and genetic instability. In the absence of severe stresses, relatively low levels of p53 are sufficient for upregulation of several genes with antioxidant products, which is associated with a decrease in intracellular ROS. Downregulation of p53 results in excessive oxidation of DNA, increased mutation rate and karyotype instability, which are prevented by incubation with the antioxidant N-acetylcysteine (NAC). Dietary supplementation with NAC prevented frequent lymphomas characteristic of Trp53-knockout mice, and slowed the growth of lung cancer xenografts deficient in p53. Our results provide a new paradigm for a nonrestrictive tumor suppressor function of p53 and highlight the potential importance of antioxidants in the prophylaxis and treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286925      PMCID: PMC2637821          DOI: 10.1038/nm1320

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  49 in total

1.  Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.

Authors:  F P Li; J E Garber; S H Friend; L C Strong; A F Patenaude; E T Juengst; P R Reilly; P Correa; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1992-08-05       Impact factor: 13.506

2.  [Effect of on various cell lines of p53 cDNA, expressed under the control of an exogenous homologous promotor].

Authors:  V S Osovskaia; B P Kopnin; N T Raĭkhlin; E a Smirnova; V S Prasolov; P M Chumakov
Journal:  Mol Biol (Mosk)       Date:  1995 Jan-Feb

3.  Effects of genetic background on tumorigenesis in p53-deficient mice.

Authors:  L A Donehower; M Harvey; H Vogel; M J McArthur; C A Montgomery; S H Park; T Thompson; R J Ford; A Bradley
Journal:  Mol Carcinog       Date:  1995-09       Impact factor: 4.784

4.  Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice.

Authors:  S D Hursting; S N Perkins; J M Phang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

5.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

6.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

Authors:  J Lin; J Chen; B Elenbaas; A J Levine
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

7.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Authors:  M L Agarwal; A Agarwal; W R Taylor; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

8.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

9.  p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.

Authors:  P A Havre; J Yuan; L Hedrick; K R Cho; P M Glazer
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

10.  Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice.

Authors:  R S Sohal; S Agarwal; M Candas; M J Forster; H Lal
Journal:  Mech Ageing Dev       Date:  1994-10-20       Impact factor: 5.432

View more
  433 in total

Review 1.  Reactive Oxygen Species: the Dual Role in Physiological and Pathological Conditions of the Human Body.

Authors:  Sanaa K Bardaweel; Mustafa Gul; Muhammad Alzweiri; Aman Ishaqat; Husam A ALSalamat; Rasha M Bashatwah
Journal:  Eurasian J Med       Date:  2018-10

Review 2.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

3.  Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.

Authors:  Cen Zhang; Meihua Lin; Rui Wu; Xiaowen Wang; Bo Yang; Arnold J Levine; Wenwei Hu; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 4.  Mitochondrial regulation of cell cycle and proliferation.

Authors:  Valeria Gabriela Antico Arciuch; María Eugenia Elguero; Juan José Poderoso; María Cecilia Carreras
Journal:  Antioxid Redox Signal       Date:  2012-01-13       Impact factor: 8.401

5.  NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration.

Authors:  Claudio Mauro; Shi Chi Leow; Elena Anso; Sonia Rocha; Anil K Thotakura; Laura Tornatore; Marta Moretti; Enrico De Smaele; Amer A Beg; Vinay Tergaonkar; Navdeep S Chandel; Guido Franzoso
Journal:  Nat Cell Biol       Date:  2011-08-28       Impact factor: 28.824

6.  Allele-specific p53 mutant reactivation.

Authors:  Xin Yu; Alexei Vazquez; Arnold J Levine; Darren R Carpizo
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

7.  Mitochondrial translocation of p53 modulates neuronal fate by preventing differentiation-induced mitochondrial stress.

Authors:  Joana M Xavier; Ana L Morgado; Susana Solá; Cecília M P Rodrigues
Journal:  Antioxid Redox Signal       Date:  2014-03-12       Impact factor: 8.401

8.  Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways.

Authors:  Maria Zamkova; Natalia Khromova; Boris P Kopnin; Pavel Kopnin
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

9.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

10.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.